Patents by Inventor Riichiro Shibakawa

Riichiro Shibakawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4605624
    Abstract: A new antibiotic substance, which has been named nargenicin C.sub.1, has been isolated from fermentations of a species of the genus Nocardia. Nargenicin C.sub.1 can be used as an antibacterial agent against susceptible bacteria, especially susceptible strains of Staphylococcus aureus.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: August 12, 1986
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4582796
    Abstract: Fermentation of a culture of Nocardia sp. ATCC 39043 produces an antibiotic complex comprising erythromycin D, 3",4"-di-O-acetylerythromycin D, 3"-O-acetyl-4"-O-propionylerythromycin D and 4"-O-acetylerythromycin D. The components are separated and are each useful in vitro and in vivo as antibacterial agents. If erythromycin D is the desired product, the esters can be hydrolyzed prior to the separation of the erythromycin D.
    Type: Grant
    Filed: April 16, 1984
    Date of Patent: April 15, 1986
    Assignee: Pfizer, Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Paul C. Watts, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4533553
    Abstract: Growth of cattle and swine is promoted and feed utilization efficiency increased by an improved nutrient feed containing the antibiotic of the formula ##STR1##
    Type: Grant
    Filed: November 9, 1983
    Date of Patent: August 6, 1985
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4496546
    Abstract: Fermentation of a culture of Nocardia sp. ATCC 39043 produces an antibiotic complex comprising erythromycin D, 3",4"-di-O-acetylerythromcyin D, 3"-O-acetyl-4"-O-propionylerythromycin D and 4"-O-acetylerythromycin D. The components are separated and are each useful in vitro and in vivo as antibacterial agents. If erythromycin D is the desired product, the esters can be hydrolyzed prior to the separation of the erythromycin D.
    Type: Grant
    Filed: April 12, 1982
    Date of Patent: January 29, 1985
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Paul C. Watts, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4450237
    Abstract: An antibiotic complex, consisting of two major components, has been isolated from fermentations of a new subspecies of Streptomyces albus culture. The two major components from the complex are two new macrolide antibiotics, which are active as antibacterial agents against certain gram-positive and gram-negative microorganisms.
    Type: Grant
    Filed: September 6, 1983
    Date of Patent: May 22, 1984
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4436747
    Abstract: A new antibiotic substance, which has been named nargenicin C.sub.1, has been isolated from fermentations of a species of the genus Nocardia. Nargenicin C.sub.1 can be used as an antibacterial agent against susceptible bacteria, especially susceptible strains of Staphylococcus aureus.
    Type: Grant
    Filed: October 21, 1982
    Date of Patent: March 13, 1984
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4431801
    Abstract: An antibiotic having the formula ##STR1## and the pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: July 23, 1982
    Date of Patent: February 14, 1984
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4411892
    Abstract: An antibiotic complex, consisting of two major components, has been isolated from fermentations of a new subspecies of Streptomyces albus culture. The two major components from the complex are two new macrolide antibiotics, which are active as antibacterial agents against certain gram-positive and gram-negative microorganisms.
    Type: Grant
    Filed: May 3, 1982
    Date of Patent: October 25, 1983
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4361649
    Abstract: A new acidic polycyclic ether antibiotic has the formula: ##STR1## and can be prepared by the submerged aerobic propagation in aqueous nutrient media of Streptomyces halstedii ATCC 31812. The antibiotic and its cationic salts are active against a variety of microorganisms and are effective in controlling coccidiosis, enteritis, swine dysentery and theileriosis as well as being effective in promotion of growth in poultry and ruminants.
    Type: Grant
    Filed: July 20, 1981
    Date of Patent: November 30, 1982
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4287182
    Abstract: Antibiotics CP-54,715 and CP-54,716, identified by their analytical characteristics, are produced by fermentation of a new microbial species Catenuloplanes jaonicus in a new genus Catenuloplanes and are active against gram-positive and anaerobic infections.
    Type: Grant
    Filed: July 2, 1980
    Date of Patent: September 1, 1981
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Liang H. Huang, John R. Oscarson, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4247462
    Abstract: A new subspecies of Streptomyces nigellus Prokop, designated Streptomyces nigellus Prokop subsp. africanus Huang subsp. nov. ATCC 31496, when propagated under aerobic conditions in aqueous nutrient media, produces a mixture of antibiotics. One of these antibiotics is the known macrolide antibiotic cirramycin A; the ansamycin antibiotic is an analogue of protostreptovaricin and the structure has been established as 21-hydroxy, 25-demethyl, 25-methylthioprotostreptovaricin I.
    Type: Grant
    Filed: January 3, 1980
    Date of Patent: January 27, 1981
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, John R. Oscarson, Liang H. Huang, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4225674
    Abstract: A new subspecies of Streptomyces nigellus Prokop, designated Streptomyces nigellus Prokop subsp. africanus Huang subsp. nov. ATCC 31496, when propagated under aerobic conditions in aqueous nutrient media, produces a mixture of antibiotics. One of these antibiotics is the known macrolide antibiotic cirramycin A; the ansamycin antibiotic is an analogue of protostreptovaricin and the structure has been established as 21-hydroxy, 25-demethyl, 25-methylthioprotostreptovaricin I.
    Type: Grant
    Filed: April 30, 1979
    Date of Patent: September 30, 1980
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, John R. Oscarson, Liang H. Huang, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4224314
    Abstract: A species of Nocardia, designated Nocardia argentinensis Huang ATCC 31438, when subjected to aerobic submerged fermentation, produces an antibiotic complex containing as its major component antibiotic Compound 51,467. Methods for the recovery and purification of antibiotic Compound 51,467 and minor antibiotic components, Compounds 52,726 and 52,748, and some of their properties are outlined.
    Type: Grant
    Filed: March 2, 1979
    Date of Patent: September 23, 1980
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Paul C. Watts, Walter P. Cullen, Liang H. Huang, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4212944
    Abstract: A new species of Nocardiopsis, designated Nocardiopsis atra Huang sp. nov. ATCC 31511, when aerobically propagated in an aqueous nutrient medium, produces nocardicin A in good yield.
    Type: Grant
    Filed: June 4, 1979
    Date of Patent: July 15, 1980
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Liang H. Huang, Mark T. Jefferson, Hiroshi Maeda, Kozo Inoue, Riichiro Shibakawa
  • Patent number: 4195079
    Abstract: A new polycyclic ether antibiotic produced by a strain of Actinomadura verrucosospora under submerged fermentation conditions is useful in controlling coccidiosis in poultry and in improving feed utilization efficiency in ruminants.
    Type: Grant
    Filed: January 31, 1979
    Date of Patent: March 25, 1980
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, John R. Oscarson, Liang H. Huang, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4169887
    Abstract: A species of Actinoplanes, designated Actinoplanes deccanensis Parenti, Pagani and Beretta subsp. salmoneus Huang subsp. nov., ATCC 31355, when subjected to submerged aerobic fermentation, produces a new antibiotic complex. Methods for the recovery and purification of the antibiotic complex and some of the individual antibiotic components are described.
    Type: Grant
    Filed: August 2, 1978
    Date of Patent: October 2, 1979
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Charles E. Moppett, Mark T. Jefferson, Liang H. Huang, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4150152
    Abstract: A new polycyclic ether antibiotic produced by a strain of Streptomyces hygroscopicus under submerged fermentation conditions is useful in controlling coccidiosis in poultry and in improving feed utilization efficiency in ruminants.
    Type: Grant
    Filed: October 26, 1977
    Date of Patent: April 17, 1979
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Charles E. Moppett, John R. Oscarson, Liang H. Huang, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4148883
    Abstract: A new species of Nocardia, designated Nocardia argentinensis Huang sp. nov., when subjected to aerobic submerged fermentation, produces a mixture of new antibiotics. Methods for the recovery and purification of these antibiotics are described and some of their antimicrobial properties are outlined.
    Type: Grant
    Filed: August 18, 1977
    Date of Patent: April 10, 1979
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Charles E. Moppett, Mark T. Jefferson, Liang H. Huang, Riichiro Shibakawa, Junsuki Tone
  • Patent number: 4148882
    Abstract: New polycyclic ether antibiotics produced by a species of actinomycete under submerged fermentation conditions are useful in controlling coccidiosis in poultry and in improving feed utilization efficiency in ruminants.
    Type: Grant
    Filed: June 24, 1977
    Date of Patent: April 10, 1979
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Charles E. Moppett, John R. Oscarson, Liang H. Huang, Riichiro Shibakawa, Junsuke Tone
  • Patent number: 4148880
    Abstract: A species of Actinoplanes, designated Actinoplanes auranticolor ATCC 31011, when subjected to submerged aerobic fermentation under controlled conditions, produces a mixture of antibiotics which includes a number of macrocyclic lactones and depsipeptides. The individual compounds exhibit significant antibiotic activity. The crude antibiotic mixture or combinations of a pure macrocyclic lactone and a pure depsipeptide demonstrate marked synergistic antibiotic activity. These antibiotics act as growth promotants in chicks and swine and are effective in the treatment of swine dysentery.This mixture of antibiotics is also produced by a species of Actinoplanes designated Actinoplanes azureus ATCC 31157. In addition, this culture produces a mixture of heptaene antibiotics with antifungal properties.
    Type: Grant
    Filed: December 16, 1976
    Date of Patent: April 10, 1979
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Charles E. Moppett, John B. Routien, Riichiro Shibakawa, Junsuke Tone